Together Pharma

Together Pharma Stock-Based Compensation

The Stock-Based Compensation (SBC) of Together Pharma (TGTR.TA) as of Oct 22, 2026 is 1.45 M ILS. In the previous year, Stock-Based Compensation (SBC) was 4.10 M ILS — a change of -64.69% (lower).

Stock-Based Compensation

1.45 MILS

YoY

-64.69%

Last updated:

Stock-Based Compensation (SBC) of Together Pharma is 2021 1.45 M ILS. Stock-Based Compensation (SBC) of Together Pharma was 2020 4.10 M ILS. It decreases by -64.69% lower compared to the previous year.

The Together Pharma Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2014
507,500.00 ILS
Jan 1, 2019
6.75 M ILS
Jan 1, 2020
4.10 M ILS
Jan 1, 2021
1.45 M ILS
The Together Pharma Stock-Based Compensation history
YEARStock-Based CompensationYoY
1.45 MILS-64.69%
4.10 MILS-39.30%
6.75 MILS+1,229.26%
507,500.00ILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Together Pharma Stock analysis

What does Together Pharma do? Together Pharma Ltd. operates through the multiplication, cultivation, production, storage, marketing, and distribution of medical products based on the cannabis plant. The company markets three specific digital products: ExactMe, which serves as a search engine for recruiters to find jobseekers; POP CV, a curriculum vitae center system that assesses, ranks, and matches resumes sent to employers; and SkilliQ, which functions as a job board. Together Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Together Pharma stock

Stock-Based Compensation (SBC) of Together Pharma is 1.45 M ILS in 2021.

Stock-Based Compensation (SBC) of Together Pharma changed from 4.10 M ILS to 1.45 M ILS, representing a -64.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Together Pharma since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Together Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Together Pharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Together Pharma